Cargando…

The ets transcription factor Fli-1 in development, cancer and disease

Friend Leukemia Virus Induced erythroleukemia-1 (Fli-1), an ETS transcription factor, was isolated a quarter century ago through a retrovirus mutagenesis screen. Fli-1 has since been recognized to play critical roles in normal development and homeostasis. For example, it transcriptionally regulates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Youjun, Luo, Heng, Liu, Tangjingjun, Zacksenhaus, Eldad, Ben-David, Yaacov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028196/ https://www.ncbi.nlm.nih.gov/pubmed/24909161 http://dx.doi.org/10.1038/onc.2014.162

Ejemplares similares

A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis
por: Liu, Tangjingjun, et al.
Publicado: (2016)

Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis
por: Liu, Tangjingjun, et al.
Publicado: (2019)

FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression
por: Wang, Chunlin, et al.
Publicado: (2019)

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
por: Shrestha, Mariusz, et al.
Publicado: (2023)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
por: Ju, YoungJun, et al.
Publicado: (2021)

FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
por: Wang, Chunlin, et al.
Publicado: (2021)

FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression
por: Hu, Jifen, et al.
Publicado: (2023)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect
por: Vecchiarelli-Federico, Laura M., et al.
Publicado: (2017)

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
por: Wang, Dong-Yu, et al.
Publicado: (2019)

ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes
por: Yu, Fang, et al.
Publicado: (2021)

Pro-inflammatory effect of a traditional Chinese medicine formula with potent anti-cancer activity in vitro impedes tumor inhibitory potential in vivo
por: Xia, Lei, et al.
Publicado: (2016)

Associations Between XPD Lys751Gln Polymorphism and Leukemia: A Meta-Analysis
por: Wen, Min, et al.
Publicado: (2018)

The vulnerability of RB loss in breast cancer: Targeting a void in cell cycle control
por: Knudsen, Erik S., et al.
Publicado: (2018)

Progression to Metastasis of Solid Cancer
por: Zacksenhaus, Eldad, et al.
Publicado: (2021)

The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease
por: Schutt, Steven D., et al.
Publicado: (2022)

Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
por: Jiang, Zhe, et al.
Publicado: (2002)

Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift
por: Ciavarra, Giovanni, et al.
Publicado: (2010)

Stratifying the stratifiers of triple negative breast cancer
por: Wang, Dong-Yu, et al.
Publicado: (2020)

UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression
por: Hu, Anling, et al.
Publicado: (2022)

Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity
por: Wang, Ning, et al.
Publicado: (2019)

A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3
por: Gajendran, Babu, et al.
Publicado: (2020)

Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3’, 5’-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells
por: Ma, Youfen, et al.
Publicado: (2020)

A Tumor initiating cell-enriched prognostic signature for HER2(+):ERα(−) breast cancer; rationale, new features, controversies and future directions
por: Liu, Jeff C., et al.
Publicado: (2013)

Methylation data of mouse Rb-deficient pineoblastoma
por: Chung, Philip E.D., et al.
Publicado: (2020)

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice
por: Li, You-Jun, et al.
Publicado: (2015)

The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
por: Lu, Diana Y., et al.
Publicado: (2023)

Critical Role of the Rb Family in Myoblast Survival and Fusion
por: Ciavarra, Giovanni, et al.
Publicado: (2011)

Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
por: Gao, Jian, et al.
Publicado: (2023)

Targeting HER2(+) breast cancer: the TBK1/IKKε axis
por: Jiang, Zhe, et al.
Publicado: (2014)

Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer
por: Wang, Sharon, et al.
Publicado: (2016)

Timing is everything: Rb’s choice in islet-cell fate
por: Cai, Erica P, et al.
Publicado: (2014)

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2(+):ERα(-) breast cancer
por: Liu, Jeffrey C., et al.
Publicado: (2017)

Elevated PI3K signaling drives multiple Breast Cancer subtypes
por: Adams, Jessica R., et al.
Publicado: (2011)

Thinking (Metastasis) outside the (Primary Tumor) Box
por: Jiang, Zhe, et al.
Publicado: (2023)

Ubiquitin-Mediated Control of ETS Transcription Factors: Roles in Cancer and Development
por: Ducker, Charles, et al.
Publicado: (2021)

Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation
por: Liu, Jeff C., et al.
Publicado: (2016)

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2015)

SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma
por: Wu, Jian, et al.
Publicado: (2021)

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
por: Liu, Jeff C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_13el891m3lilsduhgk49rdhahk